The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5078716 6109952 I 5078716-6 20051224 20060809 DIR M N 217 LBS 20060613 MD N Y UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5078716 1007572344 PS HALDOL 1 ORAL 5 MG PO Q4 HOURS PRN FOR AGITATION [RECEIVED IN 1ST 24 HOURS OF HOSPITALIZATION THEN STOPPED] Y D
5078716 1007590071 C DIPHENHYRADMINE 2

Indications of drugs used

Event ID DRUG SEQ INDI PT
5078716 1007572344 AGITATION
5078716 1007572344 BIPOLAR DISORDER
5078716 1007572344 MANIA

Outcome of event

Event ID OUTC COD
5078716 OT

Reactions reported

Event ID PT
5078716 DYSTONIA
5078716 JAW DISORDER

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5078716 1007572344 24 HR